THYMOMA MALIGNANT RECURRENT

This adverse event was reported 15 times

THYMOMA MALIGNANT RECURRENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 EFGARTIGIMOD ALFA 3 0.0008
1 IBRITUMOMAB TIUXETAN 1 0.0007
2 ATROPINE SULFATE INJECTION 1 0.0004
3 ATROPINE SULFATE MONOHYDRATE 1 0.0004
4 PYRIDOSTIGMINE BROMIDE ORAL 1 0.0003
5 PYRIDOSTIGMINE BROMIDE 1 0.0001
6 CEFTAZIDIME 1 0.0001
7 ENTECAVIR 1 0.0001
8 ROMOSOZUMAB-AQQG 1 0.0001
9 OXCARBAZEPINE 1 0.0001
See all drugs enriched for association with THYMOMA MALIGNANT RECURRENT